- ABOUT STERITAS
- STERITAS GTI
- CLINICAL SCIENCE
If you ask the doctor and patient what they want most of all, their unanimous answer will be, "not to have to use steroids."
For more than 70 years glucocorticoids have been both poison and panacea - with patients knowing the very drugs treating their conditions are also doing long-term damage.
While there are improved dosing regimens and an increasing number of steroid-sparing drugs and biologics, until now clinicians have been without a standardized measure to track the impacts of steroid-toxicity.
In the value-based care environment, the Steritas GTI provides a longitudinal and quantitative assessment of steroid-toxicity. The GTI measures toxicity in steroid-dependent patients so physicians can be vigilant in preventing treatment induced harm.
The GTI can:
“Using the GTI to monitor all people receiving glucocorticoids within a health care system would enable us to better understand the effects of glucocorticoid side effects at a population health scale, improve outcomes for patients and reduce health care inequity.”